For: | Tan B, Huang JF, Wei Q, Zhang H, Ni RZ. Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats. World J Gastroenterol 2005; 11(38): 5938-5943 [PMID: 16273603 DOI: 10.3748/wjg.v11.i38.5938] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i38/5938.htm |
Number | Citing Articles |
1 |
Hui Wang, Ying Liu, Xiu Wang, Donghui Liu, Zhiqiang Sun, Chun Wang, Gang Jin, Beiguang Zhang, Shilong Yu. Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma. Cancer 2015; 121(17): 2917 doi: 10.1002/cncr.29456
|
2 |
|
3 |
Pierre J. Dilda, Philip J. Hogg. Arsenical-based cancer drugs. Cancer Treatment Reviews 2007; 33(6): 542 doi: 10.1016/j.ctrv.2007.05.001
|
4 |
Marieta Elena Panait, Diana Chiper, Valentina Negoita, Valeria Lungu, Maria Iuliana Gruia. Therapeutic Efficacy Evaluation of 177Lu-DOTA-NT and 177Lu-DOTA-SR48692 in Murine RS-1 Hepatoma. International Journal of Peptide Research and Therapeutics 2013; 19(4): 345 doi: 10.1007/s10989-013-9358-8
|
5 |
Mohammad Mehdi Ommati, Reza Heidari, Mohammad Javad Zamiri, Samira Sabouri, Ladan Zaker, Omid Farshad, Akram Jamshidzadeh, Saeed Mousapour. The Footprints of Oxidative Stress and Mitochondrial Impairment in Arsenic Trioxide-Induced Testosterone Release Suppression in Pubertal and Mature F1-Male Balb/c Mice via the Downregulation of 3β-HSD, 17β-HSD, and CYP11a Expression. Biological Trace Element Research 2020; 195(1): 125 doi: 10.1007/s12011-019-01815-2
|
6 |
Xuanbin Wang, Yibin Feng, Ning Wang, Fan Cheung, Hor Yue Tan, Sen Zhong, Charlie Li, Seiichi Kobayashi. Chinese Medicines Induce Cell Death: The Molecular and Cellular Mechanisms for Cancer Therapy. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/530342
|
7 |
Sukhbir Nain, Judit E. G. Smits. Pathological, immunological and biochemical markers of subchronic arsenic toxicity in rats. Environmental Toxicology 2012; 27(4): 244 doi: 10.1002/tox.20635
|
8 |
Xin-Yu Zhang, Shu-Meng Yang, Hao-Peng Zhang, Yue Yang, Shi-Bo Sun, Jian-Ping Chang, Xuan-Chen Tao, Tuo-Yun Yang, Chun Liu, Yan-Mei Yang. Endoplasmic reticulum stress mediates the arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. The International Journal of Biochemistry & Cell Biology 2015; 68: 158 doi: 10.1016/j.biocel.2015.09.009
|
9 |
Jingyu Xin, Ke Zhang, Jiaqi Huang, Xiangjie Luo, Xuanqing Gong, Zhaoxuan Yang, Hongyu Lin, Hong Shan, Jinhao Gao. Facile synthesis of aquo-cisplatin arsenite multidrug nanocomposites for overcoming drug resistance and efficient combination therapy. Biomaterials Science 2019; 7(1): 262 doi: 10.1039/C8BM01039K
|
10 |
Jennifer Wu, Charles Henderson, Lynn Feun, Peter Van Veldhuizen, Philip Gold, Hui Zheng, Theresa Ryan, Lawrence S. Blaszkowsky, HaoBin Chen, Max Costa, Barry Rosenzweig, MaryLynn Nierodzik, Howard Hochster, Franco Muggia, Giovanni Abbadessa, Jonathan Lewis, Andrew X. Zhu. Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma. Investigational New Drugs 2010; 28(5): 670 doi: 10.1007/s10637-009-9286-9
|
11 |
Nak Jong Seong, Chang Jin Yoon, Sung-Gwon Kang, Jin Wook Chung, Hyo-Cheol Kim, Jae Hyung Park. Effects of Arsenic Trioxide on Radiofrequency Ablation of VX2 Liver Tumor: Intraarterial versus Intravenous Administration. Korean Journal of Radiology 2012; 13(2): 195 doi: 10.3348/kjr.2012.13.2.195
|
12 |
Hangyu Li, Jingni He, Peixin Ju, Xinping Zhong, Jingang Liu. Studies on the mechanism of arsenic trioxide-induced apoptosis in HepG2 human hepatocellular carcinoma cells. Chinese Journal of Clinical Oncology 2008; 5(1): 22 doi: 10.1007/s11805-008-0022-6
|
13 |
Hye Jin Kim, Ji Hoon Shin, Tae-Hyung Kim, Eun Young Kim, Young Soo Park, Chan-Sik Park, Ho-Young Song. Efficacy of Transarterial Embolization with Arsenic Trioxide Oil Emulsion in a Rabbit VX2 Liver Tumor Model. Journal of Vascular and Interventional Radiology 2009; 20(10): 1365 doi: 10.1016/j.jvir.2009.07.005
|